As of August 28, 2026, Filana Therapeutics, Inc. (FLNA) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. Filana Therapeutics, Inc. has a market capitalization of $74.39M, 48.31M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split
model est. 30%
• 50-day avg $1.55 approaching $1 threshold
Market Data
Market Cap$74.39M
Shares Outstanding48.31M
Float45.05M
Cash$88.67M
DebtN/A
Short InterestN/A
Institutional Holdings
29.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest6.46M
Days to Cover20.7
% of Float14.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual FLNA Dilution Snapshot
Filana Therapeutics, Inc. (FLNA) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for FLNA: xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track FLNA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking FLNA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for FLNA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.